Data / Form D filings / IconOVir Bio, Inc.
IconOVir Bio, Inc.: Form D filings
IconOVir Bio, Inc., a biotechnology company in New York, NY, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on June 4, 2024, reports $20.2 million sold of a $20.2 million offering to 34 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 689 Fifth Avenue, 12th Floor, New York, NY, 10022
- Phone
- (852) 922-9594
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1834886
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | Amendment | $20,230,000 | $20,230,000 | 34 | Jun 6, 2023 | sec.gov | |
| Jun 21, 2023 | New notice | $20,230,000 | $20,230,000 | 34 | Jun 6, 2023 | sec.gov | |
| Dec 14, 2020 | New notice | $76,998,631 | $76,998,631 | 47 | Dec 1, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sean A. Algeo | Executive Officer, Promoter | |
| Nicole M. van de Leuv | Executive Officer | |
| Helen S. Kim | Director | |
| Heba M. Nowyhed | Executive Officer | |
| David A. Chang | Director, Promoter | |
| William S. Kaelin | Director | |
| Jakob S. Loven | Director | |
| Joshua A. Kazam | Director, Promoter | |
| Julie A. Maltzman | Executive Officer | |
| Mark A. McCamish | Executive Officer, Director | |
| John A. Huynh | Executive Officer | |
| David M. Tanen | Executive Officer, Promoter |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IconOVir Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.